The organizations have agreed to collaborate over the next two years to develop the world’s first dedicated pediatric magnetoencephalography (MEG) functional brain imaging system. The pediatric system development may involve collaboration with other MEG system users. The objective would be to obtain more accurate imaging and higher resolution data for a broader range of children.
“The Children’s Hospital of Philadelphia is recognized for both its clinical excellence in pediatric care and its trailblazing research initiatives, which have resulted in significant medical advances for children,” said Jack Price, VSM MedTech’s president and CEO. “We expect our collaboration with the hospital on the development of a dedicated pediatric MEG system will create yet another such advance, supporting the clinical potential for this technology in childhood developmental applications such as dyslexia, autism and other language disorders.”
VSM MedTech has also agreed to sell a magnetoencephalography (MEG) functional brain imaging system to the hospital for both clinical and research use in children.
VSM MedTech said the system is gaining medical acceptance worldwide for real-time, high-resolution mapping of brain function due to its non-invasive approach in an environment that is comfortable for the patient. The company said its demand is increasing in the much larger clinical market for the diagnosis and treatment of neurological disorders.